Works matching DE "EFAVIRENZ-emtricitabine-tenofovir (Drug)"

Results: 81

Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2018, v. 7, n. 3, p. e148, doi. 10.1093/jpids/piy006

By:

Zash, Rebecca;
Rough, Kathryn;
Jacobson, Denise L;
Diseko, Modiegi;
Mayondi, Gloria;
Mmalane, Mompati;
Essex, Max;
Petlo, Chipo;
Lockman, Shahin;
Makhema, Joseph

Publication type:

Article

Usefulness of Methadone Plasma Concentration Measurement in Patients Receiving Nevirapine or Efavirenz.

Published in:

American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 4, p. 264, doi. 10.3109/00952990.2011.591465

By:

Pelet, Anne;
Favrat, Bernard;
Cavassini, Matthias;
Eap, Chin B.;
Besson, Jacques;
Monnat, Martine

Publication type:

Article

Bictegravir: First Global Approval.

Published in:

Drugs, 2018, v. 78, n. 5, p. 601, doi. 10.1007/s40265-018-0896-4

By:

Markham, Anthony

Publication type:

Article

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla): A Review of its Use in the Management of HIV Infection.

Published in:: Drugs, 2010, v. 70, n. 17, p. 2315, doi. 10.2165/11203800-000000000-00000
Publication type:: Article

Interaction of disulfiram with antiretroviral medications: Efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism.

Published in:

American Journal on Addictions, 2014, v. 23, n. 2, p. 137, doi. 10.1111/j.1521-0391.2013.12081.x

By:

McCance‐Katz, Elinore F.;
Gruber, Valerie A.;
Beatty, George;
Lum, Paula;
Ma, Qing;
DiFrancesco, Robin;
Hochreiter, Jill;
Wallace, Paul K.;
Faiman, Morris D.;
Morse, Gene D.

Publication type:

Article

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Published in:

2016

By:

Lortholary, Olivier;
Roussillon, Caroline;
Boucherie, Céline;
Padoin, Christophe;
Chaix, Marie-Laure;
Breton, Guillaume;
Rami, Agathe;
Veziris, Nicolas;
Patey, Olivier;
Caumes, Eric;
May, Thierry;
Molina, Jean-Michel;
Robert, Jérome;
Tod, Michel;
Fagard, Catherine;
Chêne, Geneviève;
ANRS 129 BKVIR Trial Group

Publication type:

journal article

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 685

By:

Fätkenheuer, G.;
Duvivier, C.;
Rieger, A.;
Durant, J.;
Rey, D.;
Schmidt, W.;
Hill, A.;
van Delft, Y.;
Marks, S.

Publication type:

Article

Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 675, doi. 10.1093/jac/dkr491

By:

Taylor, Stephen;
Jayasuriya, Ashini;
Fisher, Martin;
Allan, Sris;
Wilkins, Ed;
Gilleran, Gerry;
Heald, Lisa;
Fidler, Sarah;
Owen, Andrew;
Back, David;
Smit, Erasmus

Publication type:

Article

Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2601, doi. 10.1093/jac/dkr360

By:

Poeta, Julia;
Linden, Rafael;
Antunes, Marina Venzon;
Real, Lucia;
Menezes, Andréia Magalhães;
Ribeiro, Jorge P.;
Sprinz, Eduardo

Publication type:

Article

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2092

By:

Wyen, Christoph;
Hendra, Heidy;
Siccardi, Marco;
Platten, Martin;
Jaeger, Hans;
Harrer, Thomas;
Esser, Stefan;
Bogner, Johannes R.;
Brockmeyer, Norbert H.;
Bieniek, Bernhard;
Rockstroh, Juergen;
Hoffmann, Christian;
Stoehr, Albrecht;
Michalik, Claudia;
Dlugay, Verena;
Jetter, Alexander;
Knechten, Heribert;
Klinker, Hartwig;
Skaletz-Rorowski, Adriane;
Fätkenheuer, Gerd

Publication type:

Article

Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens.

Published in:

2011

By:

Maggi, Paolo;
Bellacosa, Chiara;
Carito, Valentina;
Perilli, Francesco;
Lillo, Antonio;
Volpe, Anna;
Trillo, Giovanna;
Angiletta, Domenico;
Regina, Guido;
Angarano, Gioacchino

Publication type:

journal article

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 184, doi. 10.1093/jac/dkq395

By:

Gallien, Sébastien;
Journot, Valérie;
Rozenbaum, Willy;
Yéni, Patrick;
Morlat, Philippe;
Poizot-Martin, Isabelle;
Reynes, Jacques;
Reliquet, Véronique;
Leclercq, Pascale;
Simon, François;
Chêne, Geneviève;
Molina, Jean-Michel

Publication type:

Article

Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2614, doi. 10.1093/jac/dkq369

By:

Jamshidi, Y.;
Moreton, M.;
McKeown, D. A.;
Andrews, S.;
Nithiyananthan, T.;
Tinworth, L.;
Holt, D. W.;
Sadiq, S. T.

Publication type:

Article

Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation.

Published in:

Open Forum Infectious Diseases, 2017, v. 4, n. 4, p. N.PAG, doi. 10.1093/ofid/ofx210

By:

Muhammad, Josh;
Chan, Ellen S;
Brown, Todd T;
Tebas, Pablo;
McComsey, Grace A;
Melbourne, Kathleen;
Hardin, Royce;
Willig, Amanda L;
Yin, Michael T;
Ribaudo, Heather

Publication type:

Article

De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study.

Published in:

HIV Medicine, 2024, v. 25, n. 9, p. 1019, doi. 10.1111/hiv.13655

By:

Oosterhof, P.;
de Zoete, B. G. J. A.;
Vanhommerig, J. W.;
Langebeek, N.;
Gisolf, E. H.;
van Hulzen, A. G. W.;
Lammers, A. J. J.;
Weijsenfeld, A. M.;
van der Valk, M.;
Grintjes, K.;
van Crevel, R.;
van Luin, M.;
Brinkman, K.;
Burger, D. M.

Publication type:

Article

Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).

Published in:

HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525

By:

Rancan, Ilaria;
Cassol, Chiara;
Graziani, Lucia;
Tilli, Marta;
Malcontenti, Costanza;
Russo, Chiara;
Bottanelli, Martina;
Bracchitta, Fiorenza;
Papaioannu, Rebecka;
Labate, Laura;
Mora, Sara;
Bezenchek, Antonia;
Shallvari, Adrian;
Di Biagio, Antonio;
Rossetti, Barbara

Publication type:

Article

Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.

Published in:

HIV Medicine, 2017, v. 18, n. 6, p. 412, doi. 10.1111/hiv.12518

By:

Koenig, HC;
Mounzer, K;
Daughtridge, GW;
Sloan, CE;
Lalley‐Chareczko, L;
Moorthy, GS;
Conyngham, SC;
Zuppa, AF;
Montaner, LJ;
Tebas, P

Publication type:

Article

Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial

Published in:

HIV Medicine, 2016, v. 17, n. 7, p. 505, doi. 10.1111/hiv.12349

By:

Wilkins, E;
Fisher, M;
Brogan, AJ;
Talbird, SE;
La, EM

Publication type:

Article

Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 390, doi. 10.1111/hiv.12345

By:

Rotzinger, A;
Locatelli, I;
Bugnon, O;
Fayet Mello, A;
Parienti, J‐J;
Cavassini, M;
Schneider, M.P

Publication type:

Article

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243

By:

Tiraboschi, JM;
Muñoz‐Moreno, JA;
Puertas, MC;
Alonso‐Villaverde, C;
Prats, A;
Ferrer, E;
Rozas, N;
Maso, M;
Ouchi, D;
Martinez‐Picado, J;
Podzamczer, D

Publication type:

Article

HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.

Published in:

HIV Medicine, 2014, v. 15, n. 4, p. 196, doi. 10.1111/hiv.12100

By:

Mitchell, D;
Israr, M;
Alam, S;
Dinello, D;
Kishel, J;
Jia, R;
Meyers, C

Publication type:

Article

Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.

Published in:

HIV Medicine, 2013, v. 14, n. 7, p. 401, doi. 10.1111/hiv.12017

By:

Dumond, JB;
Adams, JL;
Prince, HMA;
Kendrick, RL;
Wang, R;
Jennings, SH;
Malone, S;
White, N;
Sykes, C;
Corbett, AH;
Patterson, KB;
Forrest, A;
Kashuba, ADM

Publication type:

Article

Liver transplantation for acute liver failure due to efavirenz hepatotoxicity: the importance of routine monitoring.

Published in:

2013

By:

Fink, Douglas L;
Bloch, Edward

Publication type:

Case Study

Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naïve HIV patients.

Published in:

International Journal of STD & AIDS, 2012, v. 23, n. 5, p. 351, doi. 10.1258/ijsa.2011.011292

By:

Buscher, A.;
Hartman, C.;
Kallen, M. A.;
Giordano, T. P.

Publication type:

Article

Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine.

Published in:

International Journal of STD & AIDS, 2011, v. 22, n. 1, p. 38, doi. 10.1258/ijsa.2010.010229

By:

Bolhaar, M. G.;
Karstaedt, A. S.

Publication type:

Article

Minimum effective plasma concentration of efavirenz in treatment-naïve Chinese HIV-infected patients.

Published in:

International Journal of STD & AIDS, 2010, v. 21, n. 12, p. 810, doi. 10.1258/ijsa.2010.010114

By:

Sun, J.;
Chen, J.;
Yao, Y.;
Zhang, R.;
Zheng, Y.;
Liu, L.;
Zhang, L.;
Shen, Y.;
Lu, H.

Publication type:

Article

Change in Vitamin D Levels Occurs Early after Antiretroviral Therapy Initiation and Depends on Treatment Regimen in Resource-Limited Settings.

Published in:

PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095164

By:

Havers, Fiona P.;
Detrick, Barbara;
Cardoso, Sandra W.;
Berendes, Sima;
Lama, Javier R.;
Sugandhavesa, Patcharaphan;
Mwelase, Noluthando H.;
Campbell, Thomas B.;
Gupta, Amita

Publication type:

Article

Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study.

Published in:

PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045716

By:

Gupta, Samir K.;
Shen, Changyu;
Moe, Sharon M.;
Kamendulis, Lisa M.;
Goldman, Mitchell;
Graham, Susan Marie;
Dubé, Michael P.

Publication type:

Article

Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4<sup>+</sup> Cell Rises in HIV-Infected Patients.

Published in:

PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013188

By:

Funderburg, Nicholas;
Kalinowska, Magdalena;
Eason, James;
Goodrich, James;
Heera, Jayvant;
Mayer, Howard;
Rajicic, Natasa;
Valdez, Hernan;
Lederman, Michael M.

Publication type:

Article

Sustained HIV virologic suppression with crushed combination tablets containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.

Published in:

American Journal of Health-System Pharmacy, 2019, v. 76, n. 16, p. 1180, doi. 10.1093/ajhp/zxz132

By:

Kaplun, Olga;
Psevdos, George

Publication type:

Article

A Comparison between the Efficiency of Vonavir (Tenofovir-EmtricitabineEfavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran.

Published in:

Journal of Advanced Biomedical Sciences, 2022, v. 12, n. 3, p. 319, doi. 10.18502/jabs.v12i3.10717

By:

Saeideh, Honarmand;
Zahra, Montaseri;
Mehdi, Sharafi;
Sohrab, Najafipoor

Publication type:

Article

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experience HIV-positive patients.

Published in:

Therapeutics & Clinical Risk Management, 2017, v. 13, p. 787, doi. 10.2147/TCRM.S135972

By:

Restelli, Umberto;
Rizzardini, Giuliano;
Antinori, Andrea;
Lazzarin, Adriano;
Bonfanti, Marzia;
Bonfanti, Paolo;
Croce, Davide

Publication type:

Article

Reply to Lanzafame et al.

Published in:

2019

By:

Martin, Elizabeth A;
Hwang, Carey;
Orkin, Chloe

Publication type:

Letter to the Editor

DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug.

Published in:

2019

By:

Lanzafame, Massimiliano;
Lattuada, Emanuela;
Vento, Sandro

Publication type:

Letter to the Editor

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.

Published in:

Clinical Infectious Diseases, 2019, v. 69, n. 2, p. 207, doi. 10.1093/cid/ciy881

By:

Derache, Anne;
Iwuji, Collins C;
Baisley, Kathy;
Danaviah, Siva;
Marcelin, Anne-Geneviève;
Calvez, Vincent;
Oliveira, Tulio de;
Dabis, François;
Porter, Kholoud;
Pillay, Deenan

Publication type:

Article

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

Published in:

Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 535, doi. 10.1093/cid/ciy540

By:

Orkin, Chloe;
Squires, Kathleen E;
Molina, Jean-Michel;
Sax, Paul E;
Wong, Wing-Wai;
Sussmann, Otto;
Kaplan, Richard;
Lupinacci, Lisa;
Rodgers, Anthony;
Xu, Xia;
Lin, Gina;
Kumar, Sushma;
Sklar, Peter;
Nguyen, Bach-Yen;
Hanna, George J;
Hwang, Carey;
Martin, Elizabeth A;
Group, DRIVE-AHEAD Study

Publication type:

Article

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus– Infected Patients With Nonalcoholic Fatty Liver Disease.

Published in:

Clinical Infectious Diseases, 2017, v. 65, n. 6, p. 1012, doi. 10.1093/cid/cix467

By:

Macías, Juan;
Mancebo, María;
Merino, Dolores;
Téllez, Francisco;
Montes-Ramírez, M. Luisa;
Rivero-Juárez, Antonio;
Raffo, Miguel;
Pérez-Pérez, Montserrat;
Merchante, Nicolás;
Cotarelo, Manuel;
Pineda, Juan A.

Publication type:

Article

Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.

Published in:

Clinical Infectious Diseases, 2016, v. 63, n. 9, p. 1227, doi. 10.1093/cid/ciw500

By:

Haas, Andreas D.;
Msukwa, Malango T.;
Egger, Matthias;
Tenthani, Lyson;
Tweya, Hannock;
Jahn, Andreas;
Gadabu, Oliver J.;
Tal, Kali;
Salazar-Vizcaya, Luisa;
Estill, Janne;
Spoerri, Adrian;
Phiri, Nozgechi;
Chimbwandira, Frank;
van Oosterhout, Joep J.;
Keiser, Olivia

Publication type:

Article

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRK.

Published in:

Clinical Infectious Diseases, 2011, v. 53, n. 8, p. 807, doi. 10.1093/cid/cir510

By:

6Rockstroh, Jürgen K.;
Lennox, Jeffrey L.;
De Jesus, Edwin;
Saag, Michael S.;
Lazzarin, Adriano;
Wan, Hong;
Walker, Monica L.;
Xu, Xia;
Zhao, Jing;
Teppler, Hedy;
DiNubile, Mark J.;
Rodgers, Anthony J.;
Nguyen, Bach-Yen;
Leavitt, Randi;
Sklar, Peter

Publication type:

Article

Simultaneous Spectrophotometric Estimation of Tenofovir Disoproxil Fumarate and Lamivudine in Three Component Tablet Formulation Containing Efavirenz.

Published in:

Indian Journal of Pharmaceutical Sciences, 2010, v. 72, n. 4, p. 527, doi. 10.4103/0250-474X.73926

By:

SHARMA, R.;
MEHTA, K.

Publication type:

Article

Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir.

Published in:

Pharmacotherapy, 2011, v. 31, n. 2, p. 158, doi. 10.1592/phco.31.2.158

By:

Dlamini, Judith N.;
Zonghui Hu;
Somaroo, Harsha;
Highbarger, Helene C.;
Follmann, Dean A.;
Dewar, Robin L.;
Pau, Alice K.

Publication type:

Article

Trial watch: HIV integrase inhibitor-based regimen beats market leader.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 664, doi. 10.1038/nrd3836

By:

Crunkhorn, Sarah

Publication type:

Article

Anti-HIV Drugs Nevirapine and Efavirenz Affect Anxiety-Related Behavior and Cognitive Performance in Mice.

Published in:

Neurotoxicity Research, 2011, v. 19, n. 1, p. 73, doi. 10.1007/s12640-009-9141-y

By:

Romão, Pedro;
Lemos, Joelson;
Moreira, Jeverson;
de Chaves, Gisele;
Moretti, Morgana;
Castro, Adalberto;
Andrade, Vanessa;
Boeck, Carina;
Quevedo, João;
Gavioli, Elaine

Publication type:

Article

Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 1, p. 29, doi. 10.3109/14756360903563393

By:

Decha, Panita;
Intharathep, Pathumwadee;
Udommaneethanakit, Thanyarat;
Sompornpisut, Pornthep;
Hannongbua, Supot;
Wolschann, Peter;
Parasuk, Vudhichai

Publication type:

Article

Hepatocellular Carcinoma Developing in HIV/HBV Co-Infection: Case Presentation.

Published in:

Viral Hepatitis Journal / Viral Hepatit Dergisi, 2014, v. 20, n. 1, p. 40, doi. 10.4274/Vhd.64936

By:

İncİ, Ayşe;
FİNANCI, Muzaffer

Publication type:

Article

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years.

Published in:

Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19767

By:

Gazzard, Brian;
Marie Girard, Pierre;
Di Perri, Giovanni;
Gallant, Joel;
Towner, William;
Rogatto, Felipe;
Demorin, Jennifer;
McColl, Damian;
Liu, Hui;
Rhee, Martin;
Szwarcberg, Javier;
Piontkowsky, David

Publication type:

Article

Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.

Published in:

Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19605

By:

Peng, Siyang;
Tafazzoli, Ali;
Dorman, Emily;
Rosenblatt, Lisa;
Villasis-Keever, Angelina;
Sorensen, Sonja

Publication type:

Article

Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy.

Published in:

Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18135

By:

Cozzi-Lepri, A;
Antinori, A;
Magistrelli, E;
Castelli, F;
Rizzardini, G;
Castagna, A;
Pellizzer, G;
Abrescia, N;
Parruti, G;
Quirino, T;
Castelli, P;
Vecchiet, J;
d'Arminio Monforte, A

Publication type:

Article

Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to efavirenz/emtricitabine/tenofovir DF at week 96 in treatment-naïve HIV-1-infected patients.

Published in:

Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18219

By:

Zolopa, A;
Gallant, J;
Cohen, C;
Sax, P;
Dejesus, E;
Mills, A;
Wohl, D;
Liu, H;
Rhee, M;
Szwarcberg, J

Publication type:

Article

Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study.

Published in:

Journal of the International AIDS Society, 2010, v. 13, p. P42, doi. 10.1186/1758-2652-13-S4-P42

By:

Cooper, V;
Horne, R;
Ewan, J

Publication type:

Article